News About: Goverment
Mutual recognition of patent in Korea, China and Japan
"Patent Review Highway System" seems to be adopted to 3 far east Asian countries, Korea, Japan and China, covering that a patent be recognized through a review with priority if one country detMutual recognition of pat...
2005 Health Industry Expo to open on Dec. 8
Under a slogan of "to make a dream of human longevity without diseases come true" the MOHW and Korea Health Industry Development Institute (KHIDI) have prepared "2005 Health Industry and Technology Exhibition of Korea...
2005 Korea-EU jointly holding life science seminar on Dec. 1.
2005 Korea and EU seminar on life science will take place at Lotte hotel Sogongdong on Dec. 1.
The EU representatives in Korea, MOHW and MOIE planned a joint scientific seminar titled "2005 Korea-EU seminar on life...
Long term prescriptions for anti-appetite drugs still unchanged.
Despite the KFDA's tough restriction policy, more than 4 weeks of long term prescriptions of the anti-appetite drugs still remained uncontrolled, giving many confusion to the retail pharmacy sectors.
A pharmacy ...
HIRA and 5 medical/pharmacy groups to select internet business associates.
Health Insurance Review Agency (HIRA), Korea Pharmaceutical Association (KPA), Korea Hospital Association (KHA), Korea Medical Association (KMA), Korea Dental Association and Korea Oriental Medical Association propose...
Zydenar to complete its new drug registration
The KFDA has approved a new drug purely developed by a Korean pharmaceutical company called Zydena, an impotence drug, which will be the 10th new drug in Korea following "Factive" of LG Life Science. The KFDA announce...
No longer upper limits of NHI coverage days from next year.
The NHI (National Health Insurance) coverage duration has been restricted to no more than 365 days a year, and the extra charges beyond that period should be born by the patient's own payment under the system called "...
NHI coverage to extend Tamiflu from Dec. 1.
A massive NHI coverage will be extended to Tamiflu for the treatment of AI, taking effect from Dec. 1 this year.
The NHI reimbursement will be made for Tamiflu when medicating for the prevention and treatment of AI...
MOHW called for ethical research on stem cells.
After the press meeting of Dr. Hwang Woo-suk, a stem cell scientist, on Nov. 24 the MOHW expressed a regret over the story about the lady researcher's egg donation and made it clear that the future stem cell research ...
Government to support new drug discovery for schizophrenia.
The MOHW plans to develope AAD-200, a new candidate compount for the treatment of Alzheimer, schizophrenia and Parkinsonian disorders, which was discovered as a frontier project of the brain research in Korea.
The ...
